Clinical Talks: Combining the power of nature with the efficiency of the chemical industry
September 3 @ 09:00 – 09:30
After our recent planning hiatus, we now have the great pleasure to announce that “Clinical Talks” has been renewed for yet another exciting, innovative, and enlightening season. This season will focus on sustainable innovations within Life Sciences, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations.
Season 5, will be held September until December 2021 with a total of seven scheduled Talks, during Friday mornings 09-09:30 am via ZOOM (with some time-zone friendly adjustments for our international speakers). Each session consists of a talk given by our invited speaker followed by Q&A. The seminar is an open educational seminar series for our ever-expanding Life Science community.
Combining the power of nature with the efficiency of the chemical industry
Karim E. Cassimjee, CEO & co-Founder EnginZyme
Karim has a PhD in biotechnology from Royal Institute of Technology (KTH) and conducted postdoctoral studies in organic chemistry and quantum mechanics at Arrhenius laboratory (Stockholm University). He early found a passion for enzymes and their potential for solving the commonly unsustainable production of the chemical products used in our everyday lives and that modern society relies upon. He co-founded EnginZyme in 2014 – a company dedicated to replacing the incumbent chemical transformations that rely on heavy metal catalysts and high energy consumption, and produce a lot of bi-products. This is accomplished by developing production processes based on a proprietary and general enzyme immobilization technology applied in flow chemistry set-ups. In 2021 Karim was selected as the KTH Alumnus of the Year, and EnginZyme as Technology Pioneer by the World Economic Forum.
During the first Clinical Talks of the season, Karim will share his passion and insights for his work, technology aspirations, and experiences in pharmaceutical production, and how EnginZyme will “make the impossible possible” for a sustainable industrial large-scale production for future generations.”